ÐÂÎÅ×ÊѶ
ÄÐÐÔµÄÇ¿Ê¢£¬ £¬£¬£¬ £¬£¬£¬ÔÚÓÚ´ÓÈÝ¡ª¡ª¡ªÏ²±¨£¡º£ÄÚÊ׸ö£¡Î÷°àÑÀÔÑÐÈë¿ÚèÛéÚËáÎ÷µØÄÇ·Ç¿Ú·þ»ìÐüÒº»ñÅúÉÏÊУ¡
ÈÕÆÚ£º
2026Äê04ÔÂ03ÈÕ 14:35
èÛéÚËáÎ÷µØÄÇ·Ç¿Ú·þ»ìÐüÒº£¨ÐÒ·ö½¡®£©ÉÏÊÐÉêÇëÕýʽ»ñÅú ¡£¡£¡£¡£¡£¡£¡£¡£×÷Ϊº£ÄÚÊ׸ö¿Ú·þ»ìÐüÒº¼ÁÐ͵ÄÎ÷µØÄÇ·Ç£¬ £¬£¬£¬ £¬£¬£¬Õâ¿îÓÉÎ÷°àÑÀÔÑÐÉú²úµÄ²úÆ·£¬ £¬£¬£¬ £¬£¬£¬²»µ«Ìî²¹ÁËED£¨²ªÆð¹¦Ð§ÕÏ°£©ÖÎÁÆÁìÓòµÄ¼ÁÐÍ¿Õȱ£¬ £¬£¬£¬ £¬£¬£¬¸ü±ê¼Ç×ÅÄÐÐÔ¿µ½¡ÖÎÀíÂõÈëÁ˾«×¼¿ØÁ¿¡¢ÌåÑéÓÅÏȵÄн׶Π¡£¡£¡£¡£¡£¡£¡£¡£Ëü¼È·ÇÈ«ÐÂÒòËØ£¬ £¬£¬£¬ £¬£¬£¬Ò²·ÇÊ׷£¬ £¬£¬£¬ £¬£¬£¬¶øÊÇÖ±»÷»¼Õßδ±»Öª×ãµÄÓÃÒ©ÐèÇó£¬ £¬£¬£¬ £¬£¬£¬ÒÔ¸ÄÁ¼ÐÍÐÂÒ©µÄ×Ë̬£¬ £¬£¬£¬ £¬£¬£¬ÖØнç˵·þÒ©ÌåÑé——¸üÓÐÓ㬠£¬£¬£¬ £¬£¬£¬¸üÌåÃ棬 £¬£¬£¬ £¬£¬£¬¸ü´ÓÈÝ ¡£¡£¡£¡£¡£¡£¡£¡£
Ò»¡¢Êг¡ÏÖ×´£ºEDÖÎÁÆÐèÇóÏÔÖø£¬ £¬£¬£¬ £¬£¬£¬¹Å°åÓÃÒ©Í´µãÈÔ´æ
Ïֽ׶Î,EDÒѳÉΪӰÏìÄÐÐÔÉúÑÄÖÊÁ¿µÄÖ÷ÒªÎÊÌâÖ®Ò» ¡£¡£¡£¡£¡£¡£¡£¡£ÔÚÎÒ¹úÓÐ×ÅÖØ´óµÄ»¼Õß»ùÊý ¡£¡£¡£¡£¡£¡£¡£¡£¾Ý¹ûÕæÊý¾ÝÏÔʾ£¬ £¬£¬£¬ £¬£¬£¬ÎÒ¹úED»¼ÕßÈËÊýÔ¼1.4ÒÚÈË ¡£¡£¡£¡£¡£¡£¡£¡£¾Ý¡¶2024ÄêÖйú¿¹EDÒ©ÎïÐÐÒµ°×ƤÊé¡·ÏÔʾ£¬ £¬£¬£¬ £¬£¬£¬31-40ËêÄÐÐÔÕ¼±È44.79%£¬ £¬£¬£¬ £¬£¬£¬21-30ËêȺÌåÒ²µÖ´ï38.03%£¬ £¬£¬£¬ £¬£¬£¬·ºÆðÄêÇữÇ÷ÊÆ ¡£¡£¡£¡£¡£¡£¡£¡£
´ÓÊг¡¹æÄ£À´¿´£¬ £¬£¬£¬ £¬£¬£¬EDÒ©ÎïÈüµÀÌåÁ¿¿É¹Û£¬ £¬£¬£¬ £¬£¬£¬¶øÎ÷µØÄÇ·ÇÔÚËùÓÐEDÀàÒ©ÎïÊг¡Õ¼±È¶ÀÙÆ°ÁÍ·£¬ £¬£¬£¬ £¬£¬£¬2024ÄêÕ¼±È¸ß´ï71.96% ¡£¡£¡£¡£¡£¡£¡£¡£×÷ΪPDE5ÒÖÖƼÁµÄ½¹µãÆ·À࣬ £¬£¬£¬ £¬£¬£¬Î÷µØÄǷǸüÊDZ»º£ÄÚÍâ¶àÏîȨÍþÖ¸ÄÏ£¨È硶²ªÆð¹¦Ð§ÕÏ°Õï¶ÏÓëÖÎÁÆÖ¸ÄÏ¡·¡¶Å·ÖÞÃÚÄòѧ»áÐÔÓëÉúÖ³¿µ½¡Ö¸ÄÏ¡·µÈ£©ÁÐΪEDÖÎÁƵÄÊ×Ñ¡Ò©Î £¬£¬£¬ £¬£¬£¬ÆäÓÐÓÃÐÔÓëÇå¾²ÐÔÒÑ»ñµÃÆÕ±éÑéÖ¤ ¡£¡£¡£¡£¡£¡£¡£¡£
Ö»¹Ü¿Ú·þPDE5ÒÖÖƼÁÊÇEDÖÎÁƵÄÖ÷Á÷Ñ¡Ôñ£¬ £¬£¬£¬ £¬£¬£¬ÇÒ38.64%µÄÄÐÐÔÔø·þÓùý¿¹EDÒ©Îï1£¬ £¬£¬£¬ £¬£¬£¬µ«¹Å°åƬ¼ÁµÄÍ´µãʼÖÕÄÑÒÔ½â¾ö£¬ £¬£¬£¬ £¬£¬£¬³ÉΪ»¼ÕßÓÃÒ©µÄÒþÐÎÃż÷£º
¼ÁÁ¿Àο¿£ºÏÖÓе¥ºÐ°ü×°¼ÁÐͼÁÁ¿¾ùÒÑÀο¿£¬ £¬£¬£¬ £¬£¬£¬ÎÞ·¨Æ¥Åä¸öÌ廯ÐèÇ󣻣»£» £»£»
ÐèË®ËÍ·þ£ºÎÞ·¨Öª×ãÎÞË®Ìõ¼þÏÂËæʱËæµØÔ½·¢±ã½Ý¸øÒ©£»£»£» £»£»
Òþ˽ÞÏÞΣºÒ©Æ¬°ü×°Ò×̻¶Òþ˽£¬ £¬£¬£¬ £¬£¬£¬ÓÈÆäÔÚÉç½»³¡¾°ÏÂÓÃÒ©±ãµ±ÐÔ´ó·ùϽµ£»£»£» £»£»
ÍÌÑÊÕÏ°£ºÔ¼40.2£¥µÄÄÐÐÔ±£´æÍÌÑÊÄÑÌâ2£¬ £¬£¬£¬ £¬£¬£¬Æ¬¼ÁÄÑÒÔÖª×ãÍÌÑÊÕÏ°ÕßÓÃÒ©ÐèÇó ¡£¡£¡£¡£¡£¡£¡£¡£
¶þ¡¢ÐÒ·ö½¡®£ºÒÔ¸ÄÁ¼ÊµÏÖÌåÑéÉý¼¶¾«×¼»÷ÖÐÁÙ´²Í´µã
ÐÒ·ö½¡®µÄÉÏÊУ¬ £¬£¬£¬ £¬£¬£¬ÕýÊǶÔÕâËÄ´óÍ´µãµÄ¾«×¼»ØÓ¦£º
¾«×¼¼ÁÁ¿¶¨ÖÆ£º¼ÁÁ¿¿Éƾ֤ÐèÇóÎÞаµ÷Àí£¬ £¬£¬£¬ £¬£¬£¬25-100mg×ÔÓɵ÷½â£¬ £¬£¬£¬ £¬£¬£¬Æ¥Åä¸öÐÔ»¯ÐèÇ󣻣»£» £»£»
ʹÓÃÀû±ã¿ì½Ý£ºÎ¢·Û»¯Êèɢϵͳ£¬ £¬£¬£¬ £¬£¬£¬ÎÞÐèË®ËÍ·þ£¬ £¬£¬£¬ £¬£¬£¬ËæʱËæµØÍê³É¸øÒ©£¬ £¬£¬£¬ £¬£¬£¬ÊÊÅä¶àÔªÉúÑij¡¾°£»£»£» £»£»
È«ÐÂÓÃÒ©ÌåÑ飺°Ñ“͵͵ÃþÃþÍÌƬ”Éý¼¶Îª“×Æ˸Õý´ó¿ÚÅç¸øÒ©”£¬ £¬£¬£¬ £¬£¬£¬½â¾öÉç½»³¡¾°µÄÒþ˽ÞÏÞÎ ¡£¡£¡£¡£¡£¡£¡£¡£
ÊÊÓÃÈËȺÆձ飺ÌØÊâÊʺÏÍÌÑÊÄÑÌâ¡¢Ðè׼ȷ¼ÁÁ¿µ÷½âµÄʹÓÃÕß
Èý¡¢´Ó“ÓÐÓÔµ½“ºÃÓÔ£ºÒ»³¡¹ØÓÚ·þÒ©ÌåÑéµÄÀíÄî¸ïÃü
ÐÒ·ö½¡®µÄ»ñÅú£¬ £¬£¬£¬ £¬£¬£¬Ô¶·ÇÒ»´Î¼òÆӵļÁÐ͸ÄÁ¼£¬ £¬£¬£¬ £¬£¬£¬¶øÊÇÒ»³¡¹ØÓÚEDÖÎÁƵÄÀíÄî¸ïÃü——ÎÒÃÇÕýÔÚÖØнç˵ʲô²ÅÊÇ“ºÃÒ©” ¡£¡£¡£¡£¡£¡£¡£¡£
ºã¾ÃÒÔÀ´£¬ £¬£¬£¬ £¬£¬£¬Ò½Ò©ÐÐÒµÖ´×ÅÓÚ×·ÇóÒ©ÎïµÄ“ÓÐÓÃÐÔ”£¬ £¬£¬£¬ £¬£¬£¬È´ÍùÍùºöÂÔÁË“¿ÉÓÃÐÔ” ¡£¡£¡£¡£¡£¡£¡£¡£µ±»¼ÕßÐèÒªêþҩƬ¡¢ÕÒË®±¡¢ÅÌËãʱ¼ä¡¢ÌÓ±ÜÑÛ¹âʱ£¬ £¬£¬£¬ £¬£¬£¬Ò©ÎïµÄÁÆЧÒÑÔÚ²ã²ãÕÛËðÖдòÁËÕÛ¿Û ¡£¡£¡£¡£¡£¡£¡£¡£
ÐÒ·ö½¡®µÄ·ºÆ𣬠£¬£¬£¬ £¬£¬£¬±ê¼Ç×ÅEDÖÎÁÆÕýʽ´Ó“·þÒ©Öβ¡”µÄ1.0ʱ´ú£¬ £¬£¬£¬ £¬£¬£¬ÂõÈë“ÌåÑéÓÅÏÈ”µÄ2.0ʱ´ú ¡£¡£¡£¡£¡£¡£¡£¡£Õâ²»µ«ÊÇÊÖÒÕµÄÇ°½ø£¬ £¬£¬£¬ £¬£¬£¬¸üÊǼÛÖµ¹ÛµÄת±ä£º
-
´Ó“»¼Õß˳ӦҩÎ½“Ò©Îï˳Ӧ»¼Õß”
-
´Ó“¼òµ¥¼ÁÁ¿”µ½“¸öÐÔ»¯¼Æ»®”
-
´Ó“Ò½ÁƳ¡¾°”µ½“ÉúÑij¡¾°”
-
´Ó“Öβ¡”µ½“ÖÎÐÄ”
“¸úÓÐÇéÈË×ö¿ìÀÖÊ£¬ £¬£¬£¬ £¬£¬£¬±ðÎÊÊǽÙÊÇÔµ ¡£¡£¡£¡£¡£¡£¡£¡£”Õâ¾äÀ´×Ô¡¶Á÷¹â°¿Ïè¡·µÄ¸è´Ê£¬ £¬£¬£¬ £¬£¬£¬µÀ¾¡ÁËÈËÊÀÇé°®µÄ´¿´âÓëäìÈ÷ ¡£¡£¡£¡£¡£¡£¡£¡£¶øÒ»·Ý´ÓÈݵĵ×Æø£¬ £¬£¬£¬ £¬£¬£¬ÕýÊÇÕâ“¿ìÀÖÊ”×îºÃµÄ×îÏÈ ¡£¡£¡£¡£¡£¡£¡£¡£
ÏÖÔÚ£¬ £¬£¬£¬ £¬£¬£¬ÐÒ·ö½¡® ÔÚÒ½Ò©ÁìÓòÕÒµ½ÁËеÄ×¢½Å——ÕæÕýµÄÖÎÁÆ£¬ £¬£¬£¬ £¬£¬£¬Ó¦µ±Èû¼ÕßÔÚ×·Çó¿µ½¡µÄõ辶ÉÏ£¬ £¬£¬£¬ £¬£¬£¬±£ÓÐÓ¦ÓеĴÓÈÝÓëÌåÃæ ¡£¡£¡£¡£¡£¡£¡£¡£
ÎÒÃÇÆÚ´ýÓë¸÷½çЯÊÖ£¬ £¬£¬£¬ £¬£¬£¬ÈÃÕⳡʼÓÚ¼ÁÐ͵ÄÀå¸ï£¬ £¬£¬£¬ £¬£¬£¬×îÖÕÒý·¢Õû¸öÐÐÒµ¶Ô»¼ÕßÌåÑéµÄÖØйØ×¢ ¡£¡£¡£¡£¡£¡£¡£¡£ÓÉÓÚ£¬ £¬£¬£¬ £¬£¬£¬×îºÃµÄÒ©£¬ £¬£¬£¬ £¬£¬£¬²»µ«ÊÇÄÜÈò¡ÈËȬÓúµÄÒ©£¬ £¬£¬£¬ £¬£¬£¬¸üÊÇÈò¡ÈËÔ¸Òâ¼á³Ö·þÓõÄÒ© ¡£¡£¡£¡£¡£¡£¡£¡£
×ÊÁÏȪԴ
1¡¢2024ÄêÖйú¿¹EDÒ©ÎïÐÐÒµ°×ƤÊé
2¡¢Pharmacokinetic Parameters of a Novel SildenafiOral Liquid Suspension Administered to HealthyAdult Men Under Fasted Conditions
3¡¢ÖйúÌض¨ÈËȺÍÌÑʹ¦Ð§ÕÏ°µÄÊ¢Ðв¡Ñ§ÊӲ챨¸æ.ÖлªÎïÀíҽѧÓ뿵ÅÓºêÔ¸2017Äê12ÔµÚ39¾íµÚ12ÆÚ
4¡¢Ã×ÄÚÍøÊý¾Ý¿â¡¢²úÆ·ÁÙ´²Ñо¿Êý¾Ý
Ïà¹ØÍƼö
2021/03/01
ÍøÕ¾½¨É裺ÖÐÆó¶¯Á¦ ̨ÖÝ